從台灣健保資料庫偵測藥物副作用: 使用學習排序法

謝采璇 - 2014 - tdr.lib.ntu.edu.tw
藥物不良反應是一個相當嚴重的全球性醫療問題, 造成許多病人必須再度就醫,
更嚴重的情況甚至導致死亡. 因此, 近年來受到許多國家的重視, 進而推動藥物上市後的監控 …

使用時間關聯規則偵測臺灣人口預期外藥物不良反應

黃郁庭 - 國立臺灣大學資訊管理學系學位論文, 2017 - airitilibrary.com
藥物的使用是為了治療疾病, 但在合理用藥之情況下仍可能發生無法預期之藥物不良反應(
Adverse drug reaction, ADR). 藥物不良反應的發生影響民眾的健康, 即使國內提供全國藥物 …

從台灣健保資料庫偵測藥物副作用: 使用學習排序法

TH Hsieh - 國立臺灣大學資訊管理學系學位論文, 2014 - airitilibrary.com
Pharmacovigilance (PhV) is a serious issue worldwide, because adverse drug effects are
serious problems that cause harms to patients or even death. Traditionally, PhV research …

[引用][C] 全面性觸發工具衡量不良事件與藥物安全

陶阿倫, 吳秀玲, 許瑋真, 張旭東, 黃淑萍, 李芳菁… - 醫療品質 …, 2013 - airitilibrary.com
劉彥廷(2021). 管制藥物之多變量異常偵測與辨識–以藥局處方資料為例[碩士論文,
國立臺灣大學]. 華藝線上圖書館. https://doi. org/10.6342/NTU202102144陳巧雲(2019) …

A method for detecting adverse drug reaction signals based on retrospective cohort study using electronic medical record

박래웅, 박만영, 윤덕용 - repository.ajou.ac.kr
본 발명의 전자 의무 기록을 이용한 후향적 코호트 연구 기반의 약물 부작용 실마리 감지 방법은
(a) 부작용 여부를 파악하고자 하는 약물 및 부작용 여부를 파악하는 검사를 결정하는 단계;(b) …

Adverse Drug Event Surveillance System using Electronic Data and the Signals

김은영, 강원구, 권광일 - 한국임상약학회지, 2011 - dbpia.co.kr
약물요법에 있어 약물이상반응은 환자의 사망률과 이환율에 영향을 미치는 중요한 요인이다.
약물이상반응 발생시 이를 신속히 보고하는 것과 함께 약물치료과정에서 일어날 수 있는 약물 …

How secondary healthcare data could contribute to bridging the knowledge gap after a medical product is approved

KA Chan - Proceedings for Annual Meeting of The Japanese …, 2018 - jstage.jst.go.jp
Pre-marketing assessment of drugs relies on mechanistic studies in laboratories and clinical
trials among patients. However, drug effects observed in cellular and animal models do not …

[PDF][PDF] Using electronic healthcare records for drug safety signal detection: A comparative evaluation of statistical methods

L Scotti, JL MSc10 - MINING ELECTRONIC HEALTHCARE RECORD …, 2012 - repub.eur.nl
ABSTRACT Background and Objective. Safety monitoring of drugs post-marketing relies
primarily on spontaneous reporting, but mining of electronic healthcare records (EHR) offers …

Detection of drug risks after approval: Methods development for the use of routine statutory health insurance data

R Foraita, L Dijkstra, F Falkenberg, M Garling… - Bundesgesundheitsblatt …, 2018 - Springer
Adverse drug reactions are among the leading causes of death. Pharmacovigilance aims to
monitor drugs after they have been released to the market in order to detect potential risks …

Enhancing pharmacosurveillance with systematic collection of treatment indication in electronic prescribing: a validation study in Canada

T Eguale, N Winslade, JA Hanley, DL Buckeridge… - Drug safety, 2010 - Springer
Background: Adverse drug reaction reports used in pharmacosurveillance often lack
complete information on treatment indication that is important for benefit-risk analyses and …